|
RU2454220C2
(ru)
*
|
2006-08-16 |
2012-06-27 |
Новартис Аг |
Способ получения твердых дисперсий высококристаллических терапевтических соединений
|
|
AR076284A1
(es)
|
2009-04-29 |
2011-06-01 |
Bayer Schering Pharma Ag |
Inmunoconjugados de antimesotelina y usos de los mismos
|
|
EP4492053A3
(en)
*
|
2010-05-25 |
2025-03-19 |
F. Hoffmann-La Roche AG |
Methods of purifying polypeptides
|
|
WO2013055874A2
(en)
|
2011-10-14 |
2013-04-18 |
Genentech, Inc. |
Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
|
|
US20130195851A1
(en)
*
|
2011-12-23 |
2013-08-01 |
Genentech, Inc. |
Articles of manufacture and methods for co-administration of antibodies
|
|
CN104640560A
(zh)
*
|
2012-03-12 |
2015-05-20 |
米迪缪尼有限公司 |
用抗-cd19抗体治疗多发性硬化症
|
|
JP2015520625A
(ja)
*
|
2012-04-23 |
2015-07-23 |
ゾゲニクス インコーポレーティッド |
薬物送達カプセルのためのピストン施栓
|
|
US20150290244A1
(en)
*
|
2012-07-13 |
2015-10-15 |
The Trustees Of The University Of Pennsylvania |
Use of cart19 to deplete normal b cells to induce tolerance
|
|
AU2013201465B2
(en)
*
|
2012-10-24 |
2016-03-03 |
Rayner Intraocular Lenses Limited |
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
|
|
UA117466C2
(uk)
|
2012-12-13 |
2018-08-10 |
Мерк Шарп Енд Доме Корп. |
СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
|
|
CN110538322A
(zh)
|
2013-03-13 |
2019-12-06 |
豪夫迈·罗氏有限公司 |
抗体配制剂
|
|
CN106132434A
(zh)
*
|
2014-04-07 |
2016-11-16 |
西雅图基因公司 |
抗‑cd19抗体和抗体‑药物偶联物的稳定制剂
|
|
CA2950392A1
(en)
*
|
2014-05-28 |
2015-12-03 |
Nono Inc. |
Lyophilized formulation of tat-nr2b9c with acetylation scavenger
|
|
JP7072384B2
(ja)
|
2014-09-15 |
2022-05-20 |
ジェネンテック， インコーポレイテッド |
抗体製剤
|
|
TWI809304B
(zh)
|
2014-12-01 |
2023-07-21 |
奥默羅斯公司 |
用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
|
|
US11091543B2
(en)
|
2015-05-07 |
2021-08-17 |
Swedish Orphan Biovitrum Ag |
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
|
|
CN121588213A
(zh)
|
2015-05-07 |
2026-03-03 |
瑞典孤儿比奥维特鲁姆股份公司 |
用于诊断和治疗cxcl9和其它生物标志物水平升高的患者的病症
|
|
AR104847A1
(es)
*
|
2015-06-17 |
2017-08-16 |
Lilly Co Eli |
Formulación de anticuerpo anti-cgrp
|
|
US10493139B2
(en)
|
2015-07-24 |
2019-12-03 |
Innovative Cellular Therapeutics CO., LTD. |
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
|
|
WO2017015783A1
(en)
*
|
2015-07-24 |
2017-02-02 |
Shanghai Sidansai Biotechnology Co., Ltd |
Humanized anti-cd19 antibody and use thereof
|
|
SI3475303T1
(sl)
*
|
2016-06-27 |
2021-12-31 |
Morphosys Ag |
Formulacija protitelesa proti CD19
|
|
EP3330289A1
(en)
*
|
2016-12-02 |
2018-06-06 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
A cd33-, cd16- and cd123-specific single chain triplebody
|
|
US11077189B2
(en)
|
2017-03-02 |
2021-08-03 |
Genentech Inc. |
Adjuvant treatment of HER2-positive breast cancer
|
|
JOP20190260A1
(ar)
*
|
2017-05-02 |
2019-10-31 |
Merck Sharp & Dohme |
صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
|
|
AU2018263868A1
(en)
|
2017-05-02 |
2019-12-12 |
Merck Sharp & Dohme Llc |
Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
|
|
WO2019011918A1
(en)
|
2017-07-10 |
2019-01-17 |
International - Drug - Development - Biotech |
TREATMENT OF LYMPHOCYTE B MALIGNANCIES USING AFUCOSYLATED PRO-APOPTOTIC ANTI-CD19 ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES OR CHEMOTHERAPEUTIC AGENTS
|
|
KR102136063B1
(ko)
*
|
2017-12-06 |
2020-07-22 |
앱클론(주) |
악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항체 수용체 및 이의 용도
|
|
CN120842406A
(zh)
|
2018-10-31 |
2025-10-28 |
默沙东有限责任公司 |
抗人pd-1抗体晶体及其使用方法
|
|
CN113316458B
(zh)
|
2018-11-07 |
2024-08-02 |
默沙东有限责任公司 |
抗lag3抗体和抗pd-1抗体的共制剂
|
|
KR102735988B1
(ko)
|
2019-02-18 |
2024-12-03 |
일라이 릴리 앤드 캄파니 |
치료 항체 제제
|
|
MX2021012870A
(es)
*
|
2019-04-24 |
2022-01-18 |
Viela Bio Inc |
Uso de un anticuerpo anti cúmulo de diferenciación 19 (cd19) para tratar enfermedades autoinmunitarias.
|
|
US12544437B2
(en)
|
2019-10-04 |
2026-02-10 |
Ultragenyx Pharmaceutical Inc. |
Methods for improved therapeutic use of recombinant AAV
|
|
KR20220092578A
(ko)
*
|
2019-11-05 |
2022-07-01 |
브리스톨-마이어스 스큅 컴퍼니 |
M-단백질 검정 및 이의 용도
|
|
WO2022026914A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Alamab Therapeutics, Inc. |
Anti-connexin antibody formulations
|
|
JP2024505128A
(ja)
*
|
2020-12-30 |
2024-02-05 |
アイ－エムエービー バイオファーマ カンパニー リミテッド |
抗ｃｄ７３抗体の製剤
|
|
WO2022223028A1
(zh)
*
|
2021-04-23 |
2022-10-27 |
上海君实生物医药科技股份有限公司 |
抗BLyS抗体、其药物组合物及其用途
|
|
CN113208810B
(zh)
*
|
2021-05-18 |
2022-04-12 |
南方医科大学深圳医院 |
一种用于smile术透镜染色低温分离液的超声波给药装置
|